ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CGTX vs CSBR // ENTERPRISE SCALE & MARKET CAP

Cognition Therapeutics Inc. (NASDAQ) VS. Champions Oncology Inc. (NASDAQ) • 15-METRIC TALLY: CGTX 1 — CSBR 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CGTX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGTX VS. CSBR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CGTX CSBR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 48.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -26.90% -8.10 CSBR /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -7.52% — TIE /fcf-yield <GO>
Operating Margin — -1.90% — TIE /operating-margins <GO>
Net Profit Margin — 0.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 4.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.0 46.7 -13.71 CSBR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $70.3M $66.9M $3.4M CGTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CGTX REV CSBR REV CGTX GROSS % CSBR GROSS % CGTX FCF CSBR FCF
FY 2025 $0 $59.4M — 48.0% -$24.6M -$5.0M
FY 2024 $0 $56.9M — 50.1% -$28.5M $7.0M
FY 2023 $0 $50.2M — — -$16.0M -$6.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGTX // BETA —
CSBR // BETA —